actemra 80 mg/ 4 ml concentrate for solution for i.v. infusion
roche (philippines) inc.; distributor: zuellig pharma corporation - tocilizumab - concentrate for solution for i.v. infusion - 80 mg/ 4 ml
actemra 162 mg/ 0.9 ml solution for injection (sc)
roche (philippines), inc.; distributor: zuellig pharma corporation - tocilizumab - solution for injection (sc) - 162 mg/ 0.9 ml
actemra 162mg + 0.9ml solution for injection (sc)
zuellig pharma corporation - tocilizumab - solution for injection (sc) - 162mg + 0.9ml
actemra 162 mg /0.9 ml solución inyectable en jeringa precargada s.c.
f. hoffmann la roche s.a. - tocilizumab - tocilizumab....162 mg
actemra 20 mg/ml solution for injection/infusion solution for infusion
roche, switzerland - tocilizumab - solution for infusion - 20 mg/ml,
actemra 20 mg/ml solution for injection/infusion solution for infusion
roche, switzerland - tocilizumab - solution for infusion - 20 mg/ml,
actemra 20 mg/ml solution for injection/infusion solution for infusion
roche, switzerland - tocilizumab - solution for infusion - 20 mg/ml,
actemra 162 mg/0.9 ml solution for injection in pre-filled syringe
roche, switzerland - tocilizumab - solution for injection - 180 mg/ml
actemra 20 mg/ml concentrado para solución para infusión i.v.
f. hoffmann la roche s.a. - tocilizumab - tocilizumab....20 mg
actemra 80 infusion (parenteral)
roche products (pty) ltd - infusion (parenteral) - see ingredients - each 4,0 ml solution contains tocilizumab 80,0 mg